Literature DB >> 15377684

Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease.

G A Marshall1, D I Kaufer, O L Lopez, G R Rao, R L Hamilton, S T DeKosky.   

Abstract

BACKGROUND: Anosognosia is a common manifestation of Alzheimer's disease. There is an association between impaired awareness and frontal-executive cognitive deficits. Anosognosia is also correlated with decreased metabolism in the right hemisphere, particularly in frontal lobe regions.
OBJECTIVE: To investigate pathological correlates of anosognosia in Alzheimer's disease.
DESIGN: 41 subjects followed longitudinally in the University of Pittsburgh memory disorders clinic and with necropsy verified Alzheimer's disease were divided into two groups, based on previous clinical assessment: +Aware (n = 23) and -Aware (n = 18). A subset analysis matching subjects for dementia severity using mini-mental state examination scores was also carried out (13 +Aware; 13 -Aware). Histopathological data from necropsy brain tissue consisted of senile plaque (SP) and neurofibrillary tangle (NFT) counts (regional density) from four different brain regions in the right and left hemispheres: superior and middle frontal gyri (SMF), superior temporal isocortex (ST), the prosubiculum of the hippocampus (PRO), and the entorhinal cortex (EC).
RESULTS: SP density was greater in the right PRO region of -Aware subjects (F = 6.54, p = 0.015) than +Aware subjects. Significant differences between SP or NFT density were not observed in any other regions. In the subset analysis matching for dementia severity, SP density was again greater in the right PRO region of -Aware subjects than in the other regions (F = 12.72, p = 0.002).
CONCLUSIONS: Increased SP density in the right PRO region suggests that selective pathological involvement of this area contributes to awareness deficits in Alzheimer's disease. The putative role of the PRO in self appraisal may reflect its interconnections with other medial temporal and prefrontal regions.

Entities:  

Mesh:

Year:  2004        PMID: 15377684      PMCID: PMC1738763          DOI: 10.1136/jnnp.2003.030007

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Memory-related neural systems in Alzheimer's disease: an anatomic study.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

2.  Anterior cingulate cortex, error detection, and the online monitoring of performance.

Authors:  C S Carter; T S Braver; D M Barch; M M Botvinick; D Noll; J D Cohen
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

3.  Two domains of anosognosia in Alzheimer's disease.

Authors:  S E Starkstein; L Sabe; E Chemerinski; L Jason; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

4.  Bilateral symmetry of morphologic lesions in Alzheimer's disease.

Authors:  J Moossy; G S Zubenko; A J Martinez; G R Rao
Journal:  Arch Neurol       Date:  1988-03

5.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

6.  Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease.

Authors:  A Michon; B Deweer; B Pillon; Y Agid; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

7.  Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type.

Authors:  C Derouesné; S Thibault; S Lagha-Pierucci; V Baudouin-Madec; D Ancri; L Lacomblez
Journal:  Int J Geriatr Psychiatry       Date:  1999-12       Impact factor: 3.485

8.  Development of a scale to predict decline in patients with mild Alzheimer's disease.

Authors:  Concepcion E Santillan; Thomas Fritsch; David S Geldmacher
Journal:  J Am Geriatr Soc       Date:  2003-01       Impact factor: 5.562

9.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

10.  Anosognosia in Alzheimer's disease: a study of associated factors.

Authors:  R Migliorelli; A Tesón; L Sabe; G Petracca; M Petracchi; R Leiguarda; S E Starkstein
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1995       Impact factor: 2.198

View more
  15 in total

1.  Neuropsychological Correlates of Anosognosia for Objective Functional Difficulties in Older Adults on the Mild Cognitive Impairment Spectrum.

Authors:  Kayla A Steward; Tyler P Bull; Richard Kennedy; Michael Crowe; Virginia G Wadley
Journal:  Arch Clin Neuropsychol       Date:  2020-05-22       Impact factor: 2.813

2.  Differences in self-awareness of functional deficits between amnestic single- and multidomain mild cognitive impairment.

Authors:  Kayla A Steward; Tyler P Bull; Virginia G Wadley
Journal:  J Clin Exp Neuropsychol       Date:  2019-03-14       Impact factor: 2.475

3.  Poor awareness of IADL deficits is associated with reduced regional brain volume in older adults with cognitive impairment.

Authors:  Kayla A Steward; Richard Kennedy; Guray Erus; Ilya M Nasrallah; Virginia G Wadley
Journal:  Neuropsychologia       Date:  2019-05-04       Impact factor: 3.139

4.  Cognitive correlates of metamemory in Alzheimer's disease.

Authors:  Danielle Shaked; Meagan Farrell; Edward Huey; Janet Metcalfe; Sarah Cines; Jason Karlawish; Elizabeth Sullo; Stephanie Cosentino
Journal:  Neuropsychology       Date:  2014-05-12       Impact factor: 3.295

5.  The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults.

Authors:  Katherine A Gifford; Dandan Liu; Zengqi Lu; Yorghos Tripodis; Nicole G Cantwell; Joseph Palmisano; Neil Kowall; Angela L Jefferson
Journal:  Alzheimers Dement       Date:  2013-07-16       Impact factor: 21.566

6.  Objective metamemory testing captures awareness of deficit in Alzheimer's disease.

Authors:  Stephanie Cosentino; Janet Metcalfe; Brady Butterfield; Yaakov Stern
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

7.  Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults.

Authors:  Sterling C Johnson; Michele L Ries; Timothy M Hess; Cynthia M Carlsson; Carey E Gleason; Andrew L Alexander; Howard A Rowley; Sanjay Asthana; Mark A Sager
Journal:  Arch Gen Psychiatry       Date:  2007-10

8.  Evolution of anosognosia in alzheimer's disease and its relationship to amyloid.

Authors:  Bernard J Hanseeuw; Matthew R Scott; Sietske A M Sikkes; Michael Properzi; Jennifer R Gatchel; Eric Salmon; Gad A Marshall; Patrizia Vannini
Journal:  Ann Neurol       Date:  2019-12-05       Impact factor: 10.422

9.  Brain regions associated with anosognosia for memory disturbance in Alzheimer's disease: a magnetic resonance imaging study.

Authors:  Hiroshi Fujimoto; Teruyuki Matsuoka; Yuka Kato; Keisuke Shibata; Kaeko Nakamura; Kei Yamada; Jin Narumoto
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-05       Impact factor: 2.570

10.  Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.

Authors:  Matthias W Riepe; Thomas Mittendorf; Hans Förstl; Lutz Frölich; Martin Haupt; Reiner Leidl; Christoph Vauth; Matthias Graf von der Schulenburg
Journal:  BMC Neurol       Date:  2009-08-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.